Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

CytomX Therapeutics (CTMX) Preferred Shares Issued: 2014-2015

Historic Preferred Shares Issued for CytomX Therapeutics (CTMX) over the last 1 years, with Sep 2015 value amounting to -$250,000.

  • CytomX Therapeutics' Preferred Shares Issued was N/A to -$250,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $90.9 million, marking a year-over-year change of. This contributed to the annual value of $74.4 million for FY2015, which is 177.70% up from last year.
  • As of Q3 2015, CytomX Therapeutics' Preferred Shares Issued stood at -$250,000, which was down 100.34% from $73.5 million recorded in Q2 2015.
  • CytomX Therapeutics' Preferred Shares Issued's 5-year high stood at $73.5 million during Q2 2015, with a 5-year trough of -$250,000 in Q3 2015.
  • Over the past 2 years, CytomX Therapeutics' median Preferred Shares Issued value was $8.8 million (recorded in 2014), while the average stood at $22.7 million.